Why the study?
Does inhaled milrinone improve tolerability and weaning from CPB in high-risk cardiac surgery patients?
Does inhaled milrinone improve tolerability and weaning from CPB in high-risk cardiac surgery patients?
Preliminary experience suggests inhaled milrinone is well tolerated and may assist in weaning from cardiopulmonary bypass in high-risk cardiac surgery patients.
No takes yet. Share an insight, caveat, or question.
May support pre-CPB use in high-risk surgery; hypothesis-generating and requires randomized confirmation before practice change.
Lamarche et al. (2007) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: